Skip to main content
Livermore
Livermore
ZHEN

Acadia Pharmaceuticals Inc

ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001070494

In the last 90 days, Acadia Pharmaceuticals Inc insiders filed 0 open-market purchases and 2 sales; 354 institutions reported holding it in 13F filings for Q2 2026, worth $4.27B in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Acadia Pharmaceuticals Inc changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of ACAD: Q1 2025 compared with Q2 2025
MeasureQ1 2025Of which not filed for Q2 2025Q2 2025Change
Holders3202311−7
Shares173.0M53.7K169.8M−3.10M (−1.8%)
Value$2.87B$891.3K$3.66B+$791.9M (+27.6%)

2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (47)

Institutions that held Acadia Pharmaceuticals Inc at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to ACAD in Q2 2025
InstitutionSharesValue% of portfolio
Adage Capital Partners GP, L.L.C.603,800$13.0M0.02%
Arrowstreet Capital, Limited Partnership336,438$7.26M0.01%
Schonfeld Strategic Advisors LLC199,024$4.29M0.03%
Sphera Funds Management Ltd.174,900$3.77M0.99%
J. Goldman & Co LP164,278$3.54M0.11%
Readystate Asset Management LP91,999$1.98M0.08%
Martingale Asset Management L P69,280$1.49M0.04%
Ieq Capital, LLC47,418$1.02M0.01%
TD Asset Management Inc45,000$970.6K0.00%
UBS Oconnor LLC43,000$927.5K0.03%
OP Asset Management Ltd39,140$844.3K0.01%
Horizon Investments, LLC31,153$672.0K0.01%
Prelude Capital Management, LLC27,511$593.4K0.06%
Winton Group Ltd25,200$543.6K0.03%
Wealth Enhancement Advisory Services, LLC24,375$510.7K0.00%
Amundi20,401$433.3K0.00%
Boothbay Fund Management, LLC20,000$431.4K0.01%
Vise Technologies, Inc.14,782$318.8K0.01%
FORA Capital, LLC13,746$296.5K0.03%
Pallas Capital Advisors LLC12,664$273.2K0.01%
Yorktown Management & Research Co Inc12,050$259.9K0.25%
Pinnacle Wealth Planning Services, Inc.11,474$247.5K0.03%
Walleye Trading LLC10,624$229.2K0.01%
DRW Securities, LLC10,047$221.9K0.02%
Advyzon Investment Management, LLC9,544$205.9K0.05%
EntryPoint Capital, LLC9,541$205.8K0.10%
Glenmede Investment Management, LP2,669$57.6K0.00%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.849$18.0K0.00%
Essential Partners LLC576$12.4K0.00%
Twin Peaks Wealth Advisors, LLC318$8.09K0.00%
Whipplewood Advisors, LLC171$3.69K0.00%
Northwestern Mutual Wealth Management Co108$2.33K0.00%
Signaturefd, LLC81$1.75K0.00%
Massmutual Trust Co FSB62$1.34K0.00%
Kilter Group LLC58$1.25K0.00%
Thurston, Springer, Miller, Herd & Titak, Inc.53$1.14K0.00%
Hemington Wealth Management54$1.00K0.00%
Bare Financial Services, Inc31$6690.00%
JFS Wealth Advisors, LLC30$6480.00%
Mount Yale Investment Advisors, LLC16$3450.00%
Atlantic Trust, LLC15$3240.00%
Larson Financial Group LLC11$2370.00%
Fortitude Family Office, LLC10$2160.00%
SJS Investment Consulting Inc.9$1950.00%
HFM Investment Advisors, LLC7$1510.00%
Rialto Wealth Management, LLC2$440.00%
Parkworth Wealth Management, Inc.1$220.00%

Sold out (54)

Institutions that held Acadia Pharmaceuticals Inc at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of ACAD in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Frazier Life Sciences Management, L.P.470,338$7.81M
Schroder Investment Management Group272,882$4.66M
Avidity Partners Management LP169,000$2.81M
Baird Financial Group, Inc.90,864$1.51M
CM Management, LLC75,000$1.25M
MetLife Investment Management71,835$1.19M
Corebridge Financial, Inc.62,602$1.04M
Tudor Investment Corp Et Al58,640$974.0K
Squarepoint Ops LLC47,588$790.4K
Scientech Research LLC37,785$627.6K
ExodusPoint Capital Management, LP37,491$623.0K
Fox Run Management, L.L.C.31,938$530.5K
Shay Capital LLC28,563$474.4K
Jane Street Group, LLC27,767$461.2K
Meeder Asset Management Inc26,960$447.8K
QVT Financial LP19,613$325.8K
Mariner, LLC18,190$302.1K
Capula Management Ltd17,670$293.5K
Pacer Advisors, Inc.16,224$269.5K
Quantedge Capital Pte Ltd16,100$267.4K
Y-Intercept (Hong Kong) Ltd14,527$241.3K
Headlands Technologies LLC13,341$221.6K
PDT Partners, LLC12,327$204.8K
Empowered Funds, LLC11,188$185.8K
JustInvest LLC11,122$184.7K
111 Capital10,767$178.8K
SIH Partners, LLLP10,756$178.7K
Quarry LP9,500$157.8K
Quadrant Capital Group LLC9,258$153.8K
Quest Partners LLC9,208$152.9K
Globeflex Capital L P9,155$152.1K
Aster Capital Management (DIFC) Ltd4,431$86.8K
Quantbot Technologies LP3,142$52.2K
Caitong International Asset Management Co., Ltd2,534$42.1K
Picton Mahoney Asset Management1,936$32.0K
Coldstream Capital Management Inc1,417$23.5K
Hexagon Capital Partners LLC1,137$18.9K
PSI Advisors, LLC600$9.97K
WealthCollab, LLC384$6.38K
LRI Investments, LLC276$4.58K
High Note Wealth, LLC178$2.96K
SRS Capital Advisors, Inc.174$2.89K
Boston Private Wealth LLC166$2.76K
Bell Investment Advisors, Inc91$1.51K
Group One Trading, L.P.78$1.30K
Ritter Daniher Financial Advisory LLC63$1.05K
Avion Wealth63$1.00K
Stonebridge Financial Group, LLC60$997
Private Trust Co NA51$847
Stephens Consulting, LLC25$416
Binnacle Investments Inc19$316
Huntington National Bank12$199
AdvisorNet Financial, Inc12$199
Capital Advisors, Ltd. LLC23$0

Not filed for Q2 2025 yet (2)

Institutions that held Acadia Pharmaceuticals Inc at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ACAD in Q1 2025 that haven't filed for Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Kodai Capital Management LP53,497$888.6K
Lindbrook Capital, LLC164$2.72K